Drug Profile
JTT 654
Alternative Names: JTT-654Latest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Japan Tobacco
- Developer AKROS Pharma; Japan Tobacco
- Class Antihyperglycaemics
- Mechanism of Action 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Type 2 diabetes mellitus
Most Recent Events
- 28 Oct 2010 Discontinued - Phase-I for Type-2 diabetes mellitus in Japan (PO)
- 28 Oct 2010 Discontinued - Phase-II for Type-2 diabetes mellitus in USA (PO)
- 02 Oct 2008 Phase-I development is ongoing overseas